Molecular Research and Development
The Research and Development laboratory's major activities involve the molecular characterization of hepatitis B virus (HBV) and hepatitis C virus (HCV). The laboratory is primarily concerned with clinical research aimed at improving outcomes for patients with chronic hepatitis B and C but is also involved in basic research, clinical trial support and molecular epidemiological studies.
Main areas of research include
- Evaluation of new antiviral drugs for HBV and HCV infection
- Study of HIV and HBV co-infection and HIV and HCV co-infection
- Studies of antiviral drug resistance
- Evaluation of new molecular technologies